:::

詳目顯示

回上一頁
題名:臺灣製藥廠商的成長驅動因素--技術後進者的觀點
書刊名:產業與管理論壇
作者:許文靜吳智鴻胡美智史欽泰
作者(外文):Hsu, Wen-chingWu, Chih-hungHu, Mei-chihShih, Chin-tay
出版日期:2017
卷期:19:2
頁次:頁56+58-83
主題關鍵詞:臺灣成長驅動技術後進者製藥產業領導與治理TaiwanGrowth driversTechnological latecomersBiopharmaceutical industryLeadership and governance
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(1) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:1
  • 共同引用共同引用:41
  • 點閱點閱:93
期刊論文
1.Kang, Kyung-Nam、Park, Hayoung(2012)。Influence of Government R&D Support and Inter-Firm Collaborations on Innovation in Korean Biotechnology SMEs。Technovation,32(1),68-78。  new window
2.Hoang, H.、Rothaermel, F. T.(2010)。Leveraging Internal and External Experience: Exploration, Exploitation and R&D Project Performance。Strategic Management Journal,31(7),734-758。  new window
3.Boal, K. B.、Hooijberg, R.(2001)。Strategic leadership research: Moving on。The Leadership Quarterly,11(4),515-549。  new window
4.Lin, B. W.(2003)。Technology transfer as technological learning: a source of competitive advantage for firms with limited R&D resources。R&D Management,33(3),327-341。  new window
5.Goyal, Vidhan K.、Park, Chul W.(2002)。Board Leadership Structure and CEO Turnover。Journal of Corporate Finance,8(1),49-66。  new window
6.Heising, W.(2012)。The integration of ideation and project portfolio management: A key factor for sustainable success。International Journal of Project Management,30(5),582-595。  new window
7.Mathews, John A.(2002)。Competitive Advantages of the Latecomer Firm: A Resource-Based Account of Industrial Catch-Up Strategies。Asian Pacific Journal of Management,19(4),467-488。  new window
8.Hitt, M. A.、Ireland, R. D.、Lee, H.(2000)。Technological learning, knowledge management, firm growth and performance: An introductory essay。Journal of Engineering and Technology Management,17(3/4),231-246。  new window
9.Hung, Y.-C.、Huang, S.-M.、Lin, Q.-P.、Tsai, M.-L.(2005)。Critical factors in adopting a knowledge management system for the pharmaceutical industry。Industrial management & Data Systems,105(2),164-183。  new window
10.Mua, Q.、Lee, K.(2005)。Knowledge diffusion, market segmentation and technological catch-up: The case of the telecommunication industry in China。Research Policy,34(6),759-783。  new window
11.Ahuja, Gautam(2000)。The Duality of Collaboration: Inducements and Opportunities in the Formation of Interfirm Linkages。Strategic Management Journal,21(3),317-343。  new window
12.Uhl-Bien, M.、Marion, R.、McKelvey, B.(2007)。Complexity leadership theory: Shifting leadership from the industrial age to the knowledge era。The Leadership Quarterly,18(4),298-318。  new window
13.Kim, L.(1998)。Technology policies and strategies for developing countries: Lessons from the Korean experience。Technology Analysis & Strategic Management,10(3),311-324。  new window
14.Powell, W. W.(1998)。Learning from Collaboration: Knowledge and Networks in the Biotechnology and Pharmaceutical Industries。California Management Review,40(3),228-240。  new window
15.Bingham, Christopher B.、Eisenhardt, Kathleen M.(2008)。Position, leverage and opportunity: A typology of strategic logics linking resources with competitive advantage。Managerial and Decision Economics,29(2/3),241-256。  new window
16.Arora, A.、Gambardella, A.(1990)。Complementarity and external linkages: The strategies of the large firms in Biotechnology。Journal of Industrial Economics,38(4),361-379。  new window
17.Hite, J. M.、Hesterly, W. S.(2001)。The evolution of firm networks: from emergence to early growth of the firm。Strategic Management Journal,22(3),275-286。  new window
18.Peng, M. W.、Heath, P. S.(1996)。The growth of the firm in planned economies in transition: Institutions, organizations, and strategic choice。Academy of Management Review,21(2),492-528。  new window
19.Gulati, R. G.、Norhria, N.、Zaheer, A.(2000)。Strategic networks。Strategic Management Journal,21(3),203-215。  new window
20.Owen-Smith, Jason、Powell, Walter W.(2004)。Knowledge networks as channels and conduits: The effects of spillovers in the Boston biotechnology community。Organization Science,15(1),5-21。  new window
21.Baum, J. A. C.、Calabrese, T.、Silverman, B. S.(2000)。Don't go it alone: Alliance network composition and startups' performance in Canadian biotechnology。Strategic Management Journal,21(3),267-294。  new window
22.Daily, C. M.、McDougall, P. P.、Covin, J. G.、Dalton, D. R.(2002)。Governance and Strategic Leadership in Entrepreneurial Firms。Journal of Management,28(3),387-412。  new window
23.Hori, S.、Shimizu, Y.(1999)。Designing methods of human interface for supervisory control systems。Control Engineering Practice,7(11),1413-1419。  new window
24.Dalton, D. R.、Daily, Catherin M.、Ellstrand, A. E.、Johnson, J. L.(1998)。Meta-Analytic Reviews of Board Composition, Leadership Structure, and Financial Performance。Strategy Management Journal,19(3),269-290。  new window
25.魏聖峰(2014)。全球併購風起雲湧。先探投資週刊,1780,24-26。  延伸查詢new window
26.Bamford-Wade, A. N. I. T. A.、Moss, C.(2010)。Transformational leadership and shared governance: An action study。Journal of Nursing Management,18(7),815-821。  new window
27.Buonansegna, E.、Salomo, S.、Maier, A. M.、Li-Ying, J.(2014)。Pharmaceutical new product development: Why do clinical trials fail?。R&D Management,44(2),189-202。  new window
28.Yuqian, S.、Wenlin, G.(2014)。An empirical study on the profitability and its influencing factors of the pharmaceutical industry。Journal of Chemical and Pharmaceutical Research,6(6),1191-1195。  new window
29.Venkatraman, N.、Lee, Chi-Hyon(2004)。Preferential linkage and network evolution: A conceptual model and empirical test in the U.S. video game sector。The Academy of Management Journal,47(6),876-892。  new window
30.Torkko, M.、Linna, A.、Katajavuori, N.、Juppo, M.(2013)。Quality KPIs in pharmaceutical and food industry。Journal of Pharmaceutical Innovation,8(4),205-211。  new window
31.Scannell, W.、Blanckley, A.、Boldon, H.、Warrington, B.(2012)。Diagnosing the decline in pharmaceutical R&D efficiency。Nature Reviews Drug Discovery,11,191-200。  new window
32.Sabatier, V.、Mangematin, V.、Rousselle, T.(2010)。From recipe to dinner: Business model portfolios in the European biopharmaceutical industry。Long Range Planning,43(2/3),431-447。  new window
33.Rese, A.、Baier, D.(2011)。Success factors for innovation management in networks of small and medium enterprises。R&D Management,41(2),138-155。  new window
34.Ozawa, T.(2002)。The "hidden" side of the "flying-geese" catch-up model: Japan's dirigiste institutional setup and a deepening financial morass。Journal of Asian Economics,12(4),471-491。  new window
35.Mathews, J. A.(2006)。Dragon multinationals: New players in 21st century globalization。Asia Pacific Journal of Management,23(1),5-27。  new window
36.Markovitch, D. G.、Steckel, J. H.、Yeung, B.(2005)。Using capital markets as market intelligence: Evidence from the pharmaceutical industry。Management Science,51(10),1467-1480。  new window
37.Kermani, F.(2005)。A viewpoint on South Korean biotech。Drug Discovery Today,10(10),685-688。  new window
38.Kaufmann, D.(2013)。The influence of causation and effectuation logics on targeted policies: The cases of Singapore and Israel。Technology Analysis & Strategic Management,25(7),853-870。  new window
39.Kanungo, R. N.、Mendonca, M.(2001)。Ethical leadership and governance in organizations: A preamble。Canadian Journal of Administrative Sciences,18(4),241-243。  new window
40.Kang, K.-N.、Lee, Y.-S.(2008)。What affects the innovation performance of small and medium-sized enterprises (SMEs) in the biotechnology industry? An empirical study on Korean biotech SMEs。Biotechnology Letters,30(10),1699-1704。  new window
41.Kale, D.(2010)。The distinctive patterns of dynamic learning and inter-firm differences in the Indian pharmaceutical industry。British Journal of Management,21(1),223-238。  new window
42.Jing, F. F.、Avery, G. C.(2008)。Missing links in understanding the relationship between leadership and organizational performance。International Business & Economics Research Journal,7(5),67-78。  new window
43.Hu, M.-C.、Hung, S.-C.(2014)。Taiwan's pharmaceuticals: A failure of the sectoral system of innovation?。Technological Forecasting and Social Change,88,162-176。  new window
44.Giniatullina, A.、Boorsma, M.、Mulder, G. J.、van Deventer, S.(2013)。Building for big pharma。Nature Biotechnology,31(4),284-287。  new window
45.García-Morales, V. J.、Matias-Reche, F.、Hurtado-Torres, N.(2008)。Influence of transformational leadership on organizational innovation and performance depending on the level of organizational learning in the pharmaceutical sector。Journal of Organizational Change Management,21(2),188-212。  new window
46.Furtado, A. T.、de Freitas, A. G.(2000)。The catch-up strategy of Petrobrás through cooperative R&D。The Journal of Technology Transfer,25(1),23-36。  new window
47.Festel, G.、Schicker, A.、Boutellier, R.(2010)。Practitioner's section performance improvement in pharmaceutical R&D through new outsourcing models。Journal of Business Chemistry,7(2),89-96。  new window
48.Eid, R.、Trueman, M.、Ahmed, A. M.(2002)。A cross-industry review of B2B critical success factors。Internet Research,12(2),110-123。  new window
49.Dinh, J. E.、Lord, R. G.、Gardner, W. L.、Meuser, J. D.、Liden, R. C.、Hu, J. Y.(2014)。Leadership theory and research in the new millennium: Current theoretical trends and changing perspectives。The Leadership Quarterly,25(1),36-62。  new window
50.Christensen, L. J.、Mackey, A.、Whetten, D.(2014)。Taking responsibility for corporatesocial responsibility: The role of leaders in creating, implementing, sustaining, or avoiding socially responsible firm behaviors。The Academy of Management Perspectives,28(2),164-178。  new window
51.Cockbum, L. M.(2004)。The changing structure of the pharmaceutical industry。Health Affairs,23(1),10-22。  new window
52.Chan, A. P.-C.、Scott, D.、Chan, A. P.-L.(2004)。Factors affecting the success of a construction project。Journal of Construction Engineering and Management,130(1),153-155。  new window
53.Weitzel, W.、Jonsson, E.(1989)。Decline in organizations: A literature integration and extension。Administrative Science Quarterly,34(1),91-109。  new window
54.Shieh, Jiunn-I、Wu, Hsin-Hung、Huang, Kuan-Kai(2010)。A DEMATEL method in identifying key success factors of hospital service quality。Knowledge-Based Systems,23(3),277-282。  new window
55.Prahalad, C. K.、Hamel, Gary(1993)。Strategy as Stretch and Leverage。Harvard Business Review,71(2),75-84。  new window
56.Chang, B.、Chang, C. W.、Wu, C. H.(2011)。Fuzzy DEMATEL method for developing supplier selection criteria。Expert Systems with Applications,38(3),1850-1858。  new window
57.Eisenhardt, Kathleen M.、Martin, Jeffrey A.(2000)。Dynamic Capabilities: What Are They?。Strategic Management Journal,21(10/11),1105-1121。  new window
58.Hu, M. C.、Mathews, J. A.(2005)。National Innovative Capacity in East Asia。Research Policy,34(9),1322-1349。  new window
59.Wu, Wei-Wen(2008)。Choosing Knowledge Management Strategies by Using a Combined ANP and DEMATEL Approach。Expert Systems with Applications,35(3),828-835。  new window
60.Tzeng, Gwo-Hshiung、Chiang, Cheng-Hsin、Li, Chung-wei(2007)。Evaluating intertwined effects in e-learning programs: A novel hybrid MCDM model based on factor analysis and DEMATEL。Expert Systems with Applications,32(4),1028-1044。  new window
61.Barney, Jay B.(1991)。Firm Resources and Sustained Competitive Advantage。Journal of Management,17(1),99-120。  new window
62.Alavi, Maryam、Leidner, Dorothy E.(2001)。Knowledge Management and Knowledge Management Systems: Conceptual Foundations and Research Issues。Management Information Systems Quarterly,25(1),107-136。  new window
63.Laursen, Keld、Salter, Ammon(2006)。Open for innovation: the role of openness in explaining innovation performance among U.K. manufacturing firms。Strategic Management Journal,27(2),131-150。  new window
64.Dyer, Jeffrey H.、Singh, Harbir(1998)。The Relational View: Cooperative Strategy and Sources of Interorganizational Competitive Advantage。Academy of Management Review,23(4),660-679。  new window
65.Peng, Mike W.、Jiang, Yi、Wang, Denis Y. L.(2008)。An Institution-Based View of International Business Strategy: A Focus on Emerging Economies。Journal of International Business Studies,39(5),920-936。  new window
會議論文
1.Tamura, M.、Nagata, H.、Akazawa, K.(2002)。Extraction and Systems Analysis of Factors that Prevent Safety and Security by Structural Models。The Society of Instrument and Control Engineers Annual Conference 2002 in Osaka,(會議日期: August 5-7, 2002)。Osaka。  new window
研究報告
1.羅淑慧、廖美智、賴瓊雅、巫文玲、寇怡衡、陳怡蓁(2014)。製藥產業年鑑2014。台北:財團法人生物技術開發中心。  延伸查詢new window
學位論文
1.張喬婷(2012)。新藥研發之路:台灣生技製藥產業的技術、資金與空間連結(博士論文)。國立臺灣大學,台北。new window  延伸查詢new window
圖書
1.王振寰(20100000)。追趕的極限:臺灣的經濟轉型與創新。巨流圖書股份有限公司。new window  延伸查詢new window
2.Hofer, C. W.、Schendel, D.(1980)。Strategy formulation: Analytical concepts。St. Paul:West Publishing。  new window
3.經濟部工業局(2015)。2015生技產業白皮書。台北:經濟部工業局。  延伸查詢new window
4.吳萬益(2005)。企業研究方法。臺北:華泰文化。  延伸查詢new window
5.張紹勳(2012)。模糊多準則評估法及統計。五南圖書出版股份有限公司。  延伸查詢new window
其他
1.劉依蓁(2014)。台灣各產業景氣趨勢報告--生技醫藥,http://www.biotaiwan.org.tw/download/structure4/%E5%8A%89%E4%BE%9D%E8%93%81/103/2014%E5%8F%B0%E7%81%A3%E7%94%9F%E6%8A%80%E9%86%AB%E8%97%A5%E7%94%A2%E6%A5%AD%E5%88%86%E6%9E%90%E5%A0%Bl%E5%91%8A%20(201312).pdf。  new window
2.Bianchi, M.,Chiaroni, D.,Chiesa, V.,Frattini, F.(2012)。What makes you good at outbound open innovation: An exploratory analysis in the biotech industry,https://www.researchgate.net/profile/Mattia_Bianchi/publication/228587212_WHATMAKES_YOU_GOOD_AT_OUTBOUND_OPEN_INNOVATION_AN_EXPLORATORY_ANALYSIS_IN_THE_BIOTECH_INDUSTRY/links/0046353987092426fe000000.pdf。  new window
3.Rautiainen, T.(2001)。Critical success factors in biopharmaceutical business,https://wiki.aalto.fi/download/attachments/44302349/Critical+Success+Factors+in+Biopharmaceutical+Business+(TEKES).pdf。  new window
4.Evaluate(2016)。Evaluate Pharma world preview 2016, outlook to 2022,http://www.evaluate.com/PharmaWorldPreview2016。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關著作
 
QR Code
QRCODE